Test of donor gut bacteria for ulcerative colitis
Treatments studied
Part of Digestive system clinical trials.
This early-stage study tests whether a one-time transfer of “donor gut bacteria” can improve ulcerative colitis. It’s designed for people with mild to moderate ulcerative colitis who are stable on maintenance treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 75 years old.
- You have ulcerative colitis diagnosed within the last 12 months.
- Your ulcerative colitis is currently mild to moderate, and you are on steady maintenance therapy for at least 4–6 weeks.
- You can sign consent and reliably follow the study visits and procedures.
- In the last 2 weeks, you have not taken antibiotics, probiotics, proton pump inhibitors (acid blockers), or metformin.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether one or multiple fecal transplants from a healthy donor can help treat both a recurring C. diff infection and active ulcerative colitis. It aims to find the best schedule for the procedure.
This study tests a stool-based treatment (fecal microbiota treatment) to help remove “carbapenem-resistant” bacteria living in the gut. If you carry these bacteria without being sick, the goal is to reduce or stop that colonization.
This study looks at how fecal microbiota transplantation (FMT) affects the gut microbiome in people with ulcerative colitis, metabolic syndrome, or recurrent C. diff infection. It aims to understand how the donor bacteria settle in the gut.
This trial screens people as potential donors for a fecal microbiota transplant program used for ulcerative colitis. It checks safety and eligibility so the transplant process is as safe as possible for people with active disease.
This trial tests whether fecal microbiota transplantation (FMT) can safely and effectively treat mild to moderate ulcerative colitis over the long term. FMT involves transferring stool from a healthy donor to restore a healthy balance of gut bacteria.
This trial tests whether a stool transplant (fecal microbiota transplantation) can help manage active ulcerative colitis. You would receive a transplant from a healthy donor to see if it improves your symptoms.
Hear when a new Active Ulcerative Colitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.